2.EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):

	For the quarter ended December 31					For the nine months ended December 31
	2015			2014		2015			2014

Net earnings (loss) from continuing operations	$	(439	)	$	337	$	(6,966	)	$	(17,505	)
Net earnings (loss) from discontinued operations	(971		)	3,819		15,240			12,513

Net earnings (loss)	$	(1,410	)	$	4,156	$	8,274		$	(4,992	)


Basic earnings (loss) per share:
Basic weighted-average shares outstanding	77,831			77,039		77,903			76,998

Basic earnings (loss) per share:
Continuing operations	$	(0.01	)	$	0.00	$	(0.09	)	$	(0.23	)
Discontinued operations	$	(0.01	)	$	0.05	$	0.20		$	0.16

Net earnings (loss)	$	(0.02	)	$	0.05	$	0.11		$	(0.06	)


Diluted earnings (loss) per share:
Basic weighted-average shares outstanding	77,831			77,039		77,903			76,998
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	—			1,263		—			—

Diluted weighted-average shares outstanding	77,831			78,302		77,903			76,998

Diluted earnings (loss) per share:
Continuing operations	$	(0.01	)	$	0.00	$	(0.09	)	$	(0.23	)
Discontinued operations	$	(0.01	)	$	0.05	$	0.20		$	0.16

Net earnings (loss)	$	(0.02	)	$	0.05	$	0.11		$	(0.06	)

Some earnings (loss) per share amounts may not add due to rounding.

Due to the net loss from continuing operations incurred by the Company during the quarter and nine months ended December 31, 2015, the dilutive effect of options, warrants and restricted stock units covering 1.5 and 1.4 million shares, respectively, of common stock in each period was excluded from the diluted loss per share calculations since the impact on the calculations was anti-dilutive. Due to the net loss from continuing operations incurred by the Company during the nine months ended December 31, 2014, the dilutive effect of options, warrants and restricted stock units covering 1.3 million shares of common stock was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive.

Additional options and warrants to purchase shares of common stock and restricted stock units, including performance-based restricted stock units not meeting performance criteria, that were outstanding during the periods presented but were not included in the computation of diluted earnings (loss) per share because the effect was anti-dilutive are shown below (in thousands, except per share amounts):

	For the quarter ended December 31		For the nine months ended December 31
	2015	2014	2015	2014
Number of shares outstanding under options, warrants and restricted stock units	1,112	2,012	1,751	1,838

Range of exercise prices for options and warrants	$17.49-$62.06	$18.78-$62.06	$17.49-$62.06	$19.18-$62.06

Stockholders’ Equity

On August 29, 2011, the board of directors adopted a common stock repurchase program. That program was subsequently modified and expanded, most recently on May 19, 2015. Under the modified common stock repurchase program, the Company may purchase up to $300.0 million of its common stock through the period ending December 31, 2016. During the nine months ended December 31, 2015, the Company repurchased 1.9 million shares of its common stock for $37.5 million. Through December 31, 2015, the Company had repurchased 14.8 million shares of its stock for $240.0 million, leaving remaining capacity of $60.0 million under the stock repurchase program.

Accumulated Other Comprehensive Income

The following table presents the accumulated balances for each component of other comprehensive income (dollars in thousands):

	December 31, 2015			March 31, 2015
Foreign currency translation	$	8,194		$	9,612
Unrealized loss on interest rate swap	(53		)	(199		)

	$	8,141		$	9,413